GENIUS GROUP LTD (GNS) Fundamental Analysis & Valuation
NYSEARCA:GNS • SGXZ81555062
Current stock price
0.346 USD
-0.03 (-8.37%)
At close:
0.3489 USD
+0 (+0.84%)
After Hours:
This GNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GNS Profitability Analysis
1.1 Basic Checks
- In the past year GNS has reported negative net income.
- GNS had a negative operating cash flow in the past year.
- In the past 5 years GNS always reported negative net income.
- In the past 5 years GNS always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -29.26%, GNS is doing worse than 76.71% of the companies in the same industry.
- With a Return On Equity value of -39.98%, GNS is not doing good in the industry: 67.12% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.26% | ||
| ROE | -39.98% | ||
| ROIC | N/A |
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GNS has a Gross Margin of 32.64%. This is in the lower half of the industry: GNS underperforms 63.01% of its industry peers.
- In the last couple of years the Gross Margin of GNS has declined.
- GNS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
2. GNS Health Analysis
2.1 Basic Checks
- GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- GNS has more shares outstanding than it did 1 year ago.
- GNS has more shares outstanding than it did 5 years ago.
- GNS has a better debt/assets ratio than last year.
2.2 Solvency
- GNS has an Altman-Z score of -1.49. This is a bad value and indicates that GNS is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of GNS (-1.49) is worse than 71.23% of its industry peers.
- GNS has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
- GNS has a better Debt to Equity ratio (0.08) than 69.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.49 |
ROIC/WACCN/A
WACC9.36%
2.3 Liquidity
- GNS has a Current Ratio of 2.16. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.
- GNS has a better Current ratio (2.16) than 79.45% of its industry peers.
- A Quick Ratio of 2.12 indicates that GNS has no problem at all paying its short term obligations.
- GNS's Quick ratio of 2.12 is fine compared to the rest of the industry. GNS outperforms 79.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.16 | ||
| Quick Ratio | 2.12 |
3. GNS Growth Analysis
3.1 Past
- GNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.33%.
- Looking at the last year, GNS shows a very negative growth in Revenue. The Revenue has decreased by -65.69% in the last year.
- GNS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.48% yearly.
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.34%
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%-44.32%
3.2 Future
- GNS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.21% yearly.
- GNS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.53% yearly.
EPS Next Y62.92%
EPS Next 2Y38.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.23%
Revenue Next 2Y22.53%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. GNS Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for GNS. In the last year negative earnings were reported.
- Also next year GNS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as GNS's earnings are expected to grow with 38.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.21%
EPS Next 3YN/A
5. GNS Dividend Analysis
5.1 Amount
- No dividends for GNS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GNS Fundamentals: All Metrics, Ratios and Statistics
0.346
-0.03 (-8.37%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)09-23 2025-09-23
Earnings (Next)N/A N/A
Inst Owners1.28%
Inst Owner Change23.29%
Ins Owners8.57%
Ins Owner ChangeN/A
Market Cap55.30M
Revenue(TTM)7.91M
Net Income(TTM)-24.88M
AnalystsN/A
Price Target3.47 (902.89%)
Short Float %3.21%
Short Ratio2.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.84 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.49 | ||
| P/tB | 0.71 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.09
BVpS0.71
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.26% | ||
| ROE | -39.98% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.64% | ||
| FCFM | N/A |
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
F-Score0
Asset Turnover0.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 338.28% | ||
| Cap/Sales | 88.07% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.16 | ||
| Quick Ratio | 2.12 | ||
| Altman-Z | -1.49 |
F-Score0
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)138.36%
Cap/Depr(5y)102.77%
Cap/Sales(3y)32.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.34%
EPS Next Y62.92%
EPS Next 2Y38.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%-44.32%
Revenue Next Year-19.23%
Revenue Next 2Y22.53%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-311.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-273.5%
OCF growth 3YN/A
OCF growth 5YN/A
GENIUS GROUP LTD / GNS Fundamental Analysis FAQ
What is the fundamental rating for GNS stock?
ChartMill assigns a fundamental rating of 2 / 10 to GNS.
What is the valuation status for GNS stock?
ChartMill assigns a valuation rating of 1 / 10 to GENIUS GROUP LTD (GNS). This can be considered as Overvalued.
How profitable is GENIUS GROUP LTD (GNS) stock?
GENIUS GROUP LTD (GNS) has a profitability rating of 0 / 10.
Can you provide the financial health for GNS stock?
The financial health rating of GENIUS GROUP LTD (GNS) is 4 / 10.